Construction and expression of a human/mouse chimeric CD19 monoclonal antibody: Successful modification of a murine IgM to a chimeric IgG

By        

Experimental and Therapeutic Medicine, Vol. 7, Iss. 4, 2014-01 ,pp. : 849-854

Spandidos Publications

Access to resources Recommend Favorite

Natural IgM and IgG Antibodies to Thomsen-Friedenreich (T) Antigen in Serum of Patients with Gastric Cancer and Blood Donors: Relation to Lewis (a,b) Histo-blood Group Phenotype

By Kurtenkov Oleg   Miljukhina Ljudmila   Smorodin Jevgeni   Klaamas Kersti   Bovin Nikolai   Ellamaa Malle   Chuzmarov Valentin  

Acta Oncologica, Vol. 38, Iss. 7, 1999-11 ,pp. : 939-943

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of in vivo antineuroblastoma activity of human natural IgM

By Ollert M.W.   David K.   Vollmert C.   Juhl H.   Erttmann R.   Bredehorst R.   Vogel C.-W.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1942-1948

Elsevier

Access to resources Recommend Favorite

Expression of a 260kDa Neuroblastoma Surface Antigen, the Target of Cytotoxic Natural Human IgM: Correlation to MYCN Amplification and Effects of Retinoic Acid

By David K.   Ehrhardt A.   Ollert M.W.   Erttmann R.   Bredehorst R.   Vogel C.-W.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1937-1941

Elsevier

Access to resources Recommend Favorite

Phase I pilot clinical trial of human IgM monoclonal antibody to ganglioside GM3 in patients with metastatic melanoma

By Irie Reiko   Ollila David   O’Day Steven   Morton Donald  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 2, 2004-02 ,pp. : 110-117

Springer Publishing Company

Access to resources Recommend Favorite